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Purpose: To investigate myopic choroidal neovascularization (mCNV) by fluorescein angio­
graphy (FA), spectral­domain optical coherence tomography (SD­OCT), near­infrared (NIR) 
reflectance, and autofluorescence (AF).
Methods: This retrospective study included 65 eyes of 62 Caucasian patients with a mean 
age of 66.72 years (95% confidence interval [CI] 63–70 years) and a mean refraction of -9.72 
diopters (95% CI -8.74 to -10.70 diopters).
Results: Most of the mCNV cases were foveal­juxtafoveal (60/65, 92.3%), with thickening of 
the corresponding retina (62/65, 95.3%) and leakage on FA (44/65, 67.6%). No retinal fluid was 
detectable in 32 (49.2%) eyes and there was no hemorrhage in 25 (38.4%) eyes. Papillary chorio­
retinal atrophy was evident in 58 (89.2%), a shadowing effect in 48 (73.8%), and an epiretinal 
membrane in 38 (58.4%) eyes. If an area of macular chorioretinal atrophy was present, mCNV 
frequently developed adjacent to it and was hyperfluorescent rather than with leakage (P,0.001). 
In eyes with edema or hemorrhage, hyper­reflective foci were more frequent (P,0.005). NIR and 
AF features were indeterminable in 19 (29.2%) and 27 (41.5%) eyes, respectively. The predominant 
feature was black or grayish on NIR (34/65, 52.3%) and patchy (hypo­ and hyperfluorescence was 
observed) on AF (25/65, 38.4%). FA and SD­OCT correctly detected mCNV in 49 (75.3%) and 48 
(73.8%) eyes, respectively, whereas NIR and AF exhibited limited diagnostic sensitivity. Doubtful 
diagnosis was associated with hyperfluorescent mCNV (P,0.001), absence of retinal fluid and 
epiretinal membrane (P,0.05), and presence of macular chorioretinal atrophy (P,0.01).
Conclusion: Tomographic, angiographic, AF, and NIR features of mCNV are described in 
this study. Combination of SD­OCT and FA is recommendable for diagnosis.
Keywords: myopic neovascularization, pathologic myopia, fluorescein angiography, SD­OCT, 
imaging, CNV
Introduction
In the last few years, macular diseases have been studied better, thanks to the 
widespread use of instruments that can simultaneously combine spectral domain optical 
coherence tomography (SD­OCT) and fluorescein angiography (FA).
The Spectralis system (Heidelberg Engineering, Heidelberg, Germany) uses a solid­
state laser diode to produce light at multiple wavelengths such as 830 nm near­infrared 
(NIR) and 488 nm blue autofluorescence (AF). Digital retinal imaging can be obtained 
by direct reflectance or by emitted autofluorescence through different barrier filters. 
The active eye tracking and confocal imaging system in the platform permits focused, 
clearly defined, high­contrast FA and tomography with 40,000 A­scans per second, 
resulting in higher resolution. This “multimodal approach” is now widely employed 
in highly specialized centers, especially to examine the retina when difficulties arise 
in diagnosis or for study purposes.1
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Among macular pathologies, pathologic myopia (PM) is 
one of the main causes of vision loss in developed countries,2 
with a prevalence of 0.9%–3.1%, and it has been recently 
reported that 5.2%–11.3% of myopic individuals develop 
myopic choroidal neovascularization (mCNV).3 It is there­
fore extremely important to diagnose the condition as early 
as possible, considering, too, that these lesions respond very 
well to anti­VEGF therapy.4
The details of mCNV have been studied from the 
tomographic viewpoint, but little has been done using AF5,6 
and nothing at all with NIR. Moreover, the sensitivity of 
each of these methods is still debated, with reports of cases 
for FA varying from 60%7 up to 84.5%.8
The main aim of this study was to investigate and cor­
relate the tomographic and angiographic findings in mCNV, 
and their NIR and AF features, in a retrospective series of 
patients. A secondary aim was to evaluate the specific con­
tribution of each modality to the diagnosis.
Materials and methods
In this retrospective consecutive study, two authors (PM 
and AM), senior retina specialists, reviewed the charts and 
images of patients seen in our hospital (Istituto Auxologico 
Italiano) between 2010 and 2014. The authors advise that in 
Italy there is no need for ethical approval for retrospective 
study using imaging data or charts. In accordance with Ital­
ian law every patient signs a personal consent to allow the 
health institution they enter to manage their private medical 
information, and this type of consent was obtained by every 
patient included in the present study. 
The inclusion criteria were as follows: recent (,30 days) 
vision deterioration with metamorphopsia and/or scotoma 
at the Amsler grid test, PM, refractive error ,-6 diopters, 
staphyloma at SD­OCT, documentation or suspicion (based 
on the clinical history) of mCNV, or macular exudative 
pathologies on FA and SD­OCT. 
Exclusion criteria were previous vitreoretinal surgery, 
diabetes or signs of age­related macular degeneration (AMD), 
such as drusen, or typical geographic atrophy. Similarly, we 
excluded patients with images of unsatisfactory quality or 
presenting with vitreoretinal interface­related pathologies 
such as macular hole, epiretinal membrane (ERM), or retinal 
detachment without mCNV.
The two investigators (PM and AM) considered only 
good­quality images, at first presentation, and stored them 
in the data base of the Spectralis multimodal imaging system 
which combines confocal scanning laser angiography, simul­
taneous SD­OCT, and multiple imaging using a solid­state 
laser diode that can produce excitation light at different 
wavelengths: NIR (excitation λ=830 nm), AF and FA after 
intravenous injection of 5 mL of fluorescein (excitation 
λ=488 nm, emission .500 nm). To increase the signal­to­
noise ratio, the device is equipped with an eye tracker that 
averages multiple frames.
Only eyes for which the following images were evaluable 
were recruited:
1. NIR and AF imaging of the macular area with the 30° 
module lens set
2. FA documentation of initial (0–45 seconds), middle 
(1–2 minutes), and late (at least 3 minutes) phases of the 
macular area after intravenous injection of 2.5 mL of 
fluorescein
3. Multiple horizontal tomographic linear scans, with the 
scanner positioned on the center of the macula in the 
volume mode and, additionally, in the center of the sus­
pected lesion in the single linear mode, horizontal and 
vertical. The software has an “automatic real­time” 
(ART) function to reduce noise and improve image 
quality. With ART activated, multiple nine or 100 B­scan 
frames of the same scanning location were taken when 
using the volume or the single linear acquisition module, 
respectively.
The presence of mCNV was confirmed on the basis of the 
following features of the suspected lesion: initial dye uptake 
with hyperfluorescence and possibly late leakage on FA and 
the presence of a hyper­reflective lesion at SD­OCT.
The FA patterns of mCNV of each patient were rated 
as follows: “hyperfluorescence” (when there was only mild 
hyperfluorescence, possibly clearly circumscribed, with­
out any leakage) or “mild leakage/leakage” (if there were 
typical signs of neovascular activity, ie, initial fluorescein 
uptake by the mCNV network and extension of dye beyond 
the boundaries delineated in the early fluorescein transit).
Leakage was recorded as indistinguishable if the lesion could 
not be outlined clearly in the surrounding tissue.
The assessable neovascular complex inside the lesion 
in every volume and linear scan was also studied. The two 
investigators (PM and AM) had to establish the presence or 
absence of the following conditions:
•	 intraretinal edema (possibly with cystoid macular edema, 
intraretinal small and isolated cysts, and serous neuroreti­
nal detachment)
•	 retinal thickening anterior to the mCNV
•	 ERM in correspondence (anterior and/or immediately 
adjacent) or not in correspondence with the lesion (ie, in 
other areas of the macular region)
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•	 vitreomacular adhesion (defined as focal adhesion and/or 
traction of the posterior vitreous face within the macu­
lar region, as a sign of incomplete posterior vitreous 
detachment)
•	 hyper­reflective foci (HF).
The mCNV area was measured manually using the Spec­
tralis software (Heidelberg Eye Explorer, version 1.9.10.0; 
Heidelberg Engineering, Heidelberg, Germany), which cir­
cumscribes the lesion and calculates the area in square mm. 
The boundaries were identified in the early phase of FA, and 
then overlaid with the mouse. The mCNV was considered 
foveal­juxtafoveal if positioned 1–199 µm from the foveal 
depression, identified in the SD­OCT scan, or extrafoveal 
if positioned 200 µm or more from the center. Focal or dif­
fuse peripapillary areas of chorioretinal atrophy, contiguity 
of the lesion to an atrophic area (macular or papillary), and 
hemorrhage were noted.
A shadowing effect toward the choroid was considered 
when SD­OCT showed the typical cone of shadow, easily 
recognized when tomographic details on the outer part of the 
lesion are less evident than those around it due to the high 
reflectivity of the lesion.
In our opinion, the NIR appearance of the mCNV is not 
easy to describe because of the typical tessellated appearance 
of the macular region in PM and frequent association with 
chorioretinal atrophy. We therefore compared the mCNV 
features with the diffuse reflectance of the surrounding area. 
The lesion was defined as “pale/white” if it appeared mainly 
lighter than the adjacent retinal tissue, and “grayish” or even 
“black” if it was mostly darker. Similarly, when possible, we 
assessed the hyper­ or hypoautofluorescence, checking for 
any rings, and rated the lesion “indeterminable” if undistin­
guishable. Figure 1 shows an example of the characteristics 
investigated.
To establish the specific contribution of each of the four 
methods – NIR, AF, FA, and SD­OCT – to the diagnosis, the 
two investigators (PM and AM) showed the images of the 
selected patients to two other retina experts (SM and MS) 
on the monitor, who were then asked to what extent it was 
possible to identify mCNV on the basis of each of the single 
examinations, rating the diagnosis as “positive”, “negative”, 
or “doubtful”.
statistical analysis
We performed a descriptive analysis of the characteristics 
through the estimates of either the mean value or the percent­
age of occurrence of a specific nominal value and their 95% 
confidence interval (CI). We used correlation analysis to first 
investigate the Spearman’s pairwise correlations among the 
characteristics and then between the characteristics and the 
diagnosis with the four methods (FA, SD­OCT, NIR, and 
AF). The value of P may range between 1, indicating a perfect 
correlation, and -1, indicating a perfect inverse (negative) 
correlation. Then, we performed a multivariate canonical 
correlation and a factorial analysis in order to highlight 
possible relationships among the characteristics.
We used Wilcoxon test to compare the average behavior 
of every variable (eg, presence/absence of HF) between the 
two subgroups (eg, presence/absence of hemorrhage). Finally, 
we compared the performance of each of the four diagnostic 
methods. The proportion of agreement for pairs was assessed 
using the Cohen’s kappa (κ) statistic and the overall agree­
ment using the κ
m
 statistic (k,0 [poor agreement]; k=0–0.20 
[slight agreement], 0.21–0.40 [fair], 0.41–0.60 [moderate], 
0.61–0.8 [substantial]; and k.0.81 [almost perfect agree­
ment]). All analyses were done with SAS software version 9.2 
(SAS Institute Inc., Cary, NC, USA).
Results
Sixty­five eyes of 62 patients (44 females and 21 males), all 
Caucasians, met the criteria for inclusion in the study. Mean 
age was 66.72 years (95% CI 63-70), range 18 to 89. Mean 
refraction was -9.72 diopters, range -6 to -22 (95% CI -8.74 
to -10.70). Table 1 lists the FA and OCT characteristics.
Most of the mCNV cases were foveal­juxtafoveal (60/65, 
92.3%); small (mean area 1.51 mm2); and presented with 
hemorrhage (40/65, 61.6%), thickening of the corresponding 
retina (62/65, 95.3%) at OCT, and leakage (44/65, 67.6%) 
on FA. In 32 eyes (49.2%), no retinal fluid of any type was 
detectable. Papillary chorioretinal atrophy was evident in 
58 (89.2%) and ERM in 38 (58.4) eyes. Neovascularization 
developed on the edge of a chorioretinal atrophic lesion 
(macular or papillary) in 18/65 eyes (27.6%) and in one eye 
presented with two distinct but contiguous areas of leakage.
The appearance on NIR and AF varied widely and was 
indeterminable in 19 (29.2%) and 27 cases (41.5%), respec­
tively. It was predominantly black or grayish on NIR (34/65, 
52.3%) and hypo­hyperautofluorescent on AF (“patchy”, 
25/65, 38.4%). The lesion was surrounded by a ring either 
on NIR or on AF in 37 cases (28.4%) (Table 2). 
In eyes with edema or hemorrhage, the prevalence of HF 
was more frequent than in eyes without (64.2% vs 25.4%, 
P,0.05 and 72.0% vs 32.5%, P,0.05). 
If macular chorioretinal atrophy was present, hemor­
rhages were much less frequent (P,0.05); mCNV often 
developed adjacent to it or to an area of peripapillary atrophy 
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Figure 1 Macular images of the right eye of a 50-year-old man with new-onset foveal myopic choroidal neovascularization (refractive error, 10 diopters).
Notes: On autofluorescence (A), the lesion appeared hypoautofluorescent, circumscribed by a hyperautofluorescent ring (red arrowhead). Early (B) and late (C) fluorescein 
angiography frames show a hyperfluorescent lesion with late leakage (white arrowhead). Horizontal (D and E) and vertical (F and G) sD-OCT scans through the lesion show 
a hyper-reflective lesion with thickening of the corresponding retina (blue arrow), epiretinal membrane (green arrowhead), shadowing effect toward the choroid (yellow 
arrowhead in image E), and limited serous neuroretinal detachment (red circle). The white arrow in image F shows the position and the direction of the sD-OCT scan. 
Neovascularization was diagnosed on the basis of SD-OCT or fluorescein angiography findings, but not on the basis of autofluorescence or near-infrared imaging.
Abbreviation: sD-OCT, spectral-domain optical coherence tomography.
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(ρ=0.6, P,0.0001) and was more frequently hyperfluores­
cent on FA rather than with leakage (P,0.0001).
Doubtful diagnosis on FA was significantly related to 
a higher percentage of eyes with macular choroidal atro­
phy (P,0.001), with mCNV close to choroidal atrophy 
(P,0.001) and with hyperfluorescent mCNV (P,0.001).
In the group with doubtful diagnosis at SD­OCT, there 
was a higher percentage of eyes without any kind of retinal 
fluid (P,0.05) and a smaller percentage of eyes with HF 
(P,0.05), hemorrhage (P,0.05), ERM (P,0.05), and 
leakage (P,0.01). We also observed a higher percentage of 
lesions close to the region of choroidal atrophy (P,0.01).
Table 3 presents the majority of significant comparisons.
Diagnostic difficulties of SD­OCT and FA were associ­
ated (ρ=0.47, P,0.0001) as were positive cases diagnosed 
by NIR and AF (ρ=0.77, P,0.0001), which also resulted in 
discrete correlation with the presence of hemorrhage, HF, and 
larger mCNV (R².0.4, P.0.4). In fact, AF and NIR were of 
Table 1 Epidemiologic and morphologic features of patients with pathologic myopia complicated by CNV (65 eyes)
Characteristics Mean 95% CI 
age (years) 66.72 63.08, 70.37
refraction (diopters) -9.72 -10.70, -8.74
area (m2) 1.51 1.00, 2.03
Values n (%) 95% CI 
sex Female 44 (67.79) 0.56, 0.79
Male 21 (32.31) 0.21, 0.44
Position extrafoveal 5 (7.69) 0.01, 0.14
Foveal 60 (92.31) 0.86, 0.99
lens status natural 40 (61.54) 0.49, 0.74
Pseudophakic 21 (32.31) 0.21, 0.44
refractive surgery 4 (6.15) 0.00, 0.12
hemorrhage Yes 40 (61.54) 0.49, 0.74
no 25 (38.46) 0.26, 0.51
serous neuroretinal detachment no 47 (72.31) 0.61, 0.83
Yes 18 (27.69) 0.17, 0.39
All kinds of retinal edema (SND, 
intraretinal edema, CMe, isolated cysts)
Yes
no
33 (50.77)
32 (49.23)
0.38, 0.63
0.37, 0.62
erM no 27 (41.54) 0.29, 0.54
Yes 38 (58.46) 0.46, 0.71
Corresponding retina thickening no 2 (3.08) 0.00, 0.08
Yes 62 (95.38) 0.90, 1.00
Doubtful 1 (1.54) 0.00, 0.05
Hyper-reflective foci Yes 22 (33.85) 0.22, 0.46
no 40 (61.54) 0.49, 0.74
Doubt 3 (4.62) 0.00, 0.10
Vitreomacular adhesion no 61 (93.84) 0.87, 0.99
Yes 2 (3.08) 0.00, 0.07
Doubtful 2 (3.08) 0.00, 0.07
shadowing effect no 11 (16.92) 0.08, 0.26
Yes 48 (73.85) 0.63, 0.85
Doubtful 6 (9.23) 0.02, 0.16
Papillary chorioretinal atrophy no 7 (10.77) 0.03, 0.19
Yes 58 (89.23) 0.81, 0.97
Macular chorioretinal atrophy no 41 (63.08) 0.51, 0.75
Yes 24 (36.92) 0.25, 0.49
mCNV on the border of chorioretinal 
atrophy (macular or papillary)
no
Yes
47 (72.31)
18 (27.69)
0.61, 0.83
0.17, 0.39
Fa appearance Hyperflourescence 15 (23.08) 0.13, 0.34
Leakage 44 (67.69) 0.66, 0.87
Mild leakage 6 (9.23) 0.02, 0.16
Abbreviations: CNV, choroidal neovascularization; SND, serous neuroretinal detachment; CME, cystoids macular edema; ERM, epiretinal membrane; mCNV, myopic 
choroidal neovascularization; FA, fluorescein angiography.
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some diagnostic utility (ρ ∈[0.4, 0.53] P,0.0001) only in 
eyes with hemorrhage, cystoid macular edema, or edema.
FA and SD­OCT offered similar diagnostic sensitivity 
(k=0.5), as mCNV was properly detected in 49 (75.3%) 
and 48 (73.8%) eyes, respectively, on the basis of single 
modality (Table 4).
There was no significant difference in the dimension of 
the lesion with respect to age and refraction. Leakage on 
FA was more prominent in patients younger than 66 years 
(P,0.05) and did not differ statistically between the eyes 
with or without edema (P=0.35). Hyperfluorescence on FA, 
ERM, and the shadowing effect seemed to be more frequent 
in older patients (P,0.05).
Discussion
Numerous papers have been published on the multimodal 
description of retinal lesions, but not on mCNV, especially in 
Caucasians. The present study, though only covering a fairly 
small series of patients, shows up many important features of 
mCNV, some known and others unknown, such as the fre­
quent presence of ERM (38/65, 58.4%), especially in larger 
lesions and in older patients. In 6/65 (9.2%) cases, ERM was 
present only at the site of mCNV, in 19 (29.2%) it involved 
the entire macular area, and in 13 (19.9%) it was outside the 
mCNV area. The prevalence of ERM varies across studies, 
and comparison is problematic. Similar to the nonmyopic 
population, the findings in myopic eyes also vary widely: 
from 23% in Chinese9 to 11%–40% in Caucasians.10,11 The 
relationship between ERM and CNV has not been widely 
investigated, but many authors found lower rates of poste­
rior vitreous detachment in eyes with exudative AMD than 
in eyes with dry AMD or no disease.12–14 Since statistically 
relevant association was also observed between CNV and 
VMA (located just anterior to the CNV area) in 19%–28% of 
patients with exudative AMD,15,16 it has been suggested that 
persistent attachment of the posterior vitreous cortex to the 
macula may be a risk factor for the development of CNV. The 
early vitreous fluidification and detachment, which typically 
occur prematurely in high myopia,17 and the relative older 
mean age of patients may also explain the larger proportion 
of ERM in our study.
Another interesting finding is the occurrence of very high 
frequency of peripapillary chorioretinal atrophy (89.2%), 
slightly more prevalent than reported in myopic patients 
without mCNV (81.2%).18 This finding is very common in 
PM and was recently reported to be negatively related to 
visual acuity improvement after intravitreal injection19 and 
to be the only relevant factor associated with the need for 
retreatment.20 Peripapillary atrophy may be secondary to the 
degree of choroidal ischemia in PM, as choroidal circulatory 
disturbances may contribute to crescent development and 
enlargement over the years21 and to mCNV onset. As was 
found in other studies, macular chorioretinal atrophy in our 
series was also less prevalent than papillary atrophy, and this 
was probably because of differences in circulation. Overall, 
it is not surprising that 47/65 mCNVs developed on the edge 
of an area of chorioretinal atrophy, macular or papillary, pre­
sumably in response to an ischemic cause. Increased thinning 
of the retina in the border of areas of chorioretinal atrophy 
may account for higher prevalence of hyperfluorescence than 
leakage on FA and to fewer hemorrhages (P,0.05).
We have no explanations for the low prevalence of serous 
neuroretinal fluid at SD­OCT (27% compared to 60% in 
CNV secondary to AMD22), although we can speculate that 
it might be secondary to the lower activity of mCNV. The HF 
observed in the neovascular complex have also been found 
to be commonly associated with CNV in AMD, with retinal 
vein occlusion and diabetic macular edema. HF are thought 
to be migrating retinal pigment epithelium (RPE) cells or 
leucocytes, or very initial intraretinal lipoprotein exudates, 
and therefore their presence is a sign of lesion activity.23,24 In 
our study, HF appeared to be clearly related to the presence 
of retinal edema, serous neuroretinal detachment, and hem­
orrhage (P,0.05, Table 3), thus confirming the association 
with exudative retinal changes.
The shadowing effect toward the choroid is intuitively 
due to the hyper­reflectivity of the thickened retina–mCNV 
Table 2 Characteristics of mCNV assessed by near-infrared 
(NIR) reflectance and autofluorescence (AF); (65 eyes)
NIR reflectance 
and AF
Appearance n (%) 95% CI 
nir Black 5 (7.69) 0.01, 0.14
Black, grayish ring 1 (1.54) 0.00, 0.05
Black, white ring 3 (4.62) 0.00, 0.10
Black, white 2 (3.08) 0.00, 0.07
grayish 7 (10.77) 0.03, 0.19
Grayish, black ring 6 (9.23) 0.02, 0.16
grayish, white ring 10 (15.38) 0.06, 0.24
Grayish, black 2 (3.08) 0.00, 0.07
White 3 (4.62) 0.00, 0.10
White, grayish ring 2 (3.08) 0.00, 0.07
White, grayish 5 (7.69) 0.01, 0.14
Undetermined 19 (29.23) 0.18, 0.41
aF hyper 8 (12.31) 0.04, 0.21
hypo 5 (7.69) 0.01, 0.14
hypo, ring hyper 15 (23.08) 0.13, 0.34
hypo-hyper 10 (15.38) 0.06, 0.24
Undetermined 27 (41.54) 0.29, 0.54
Abbreviation: mCnV, myopic choroidal neovascularization.
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complex, and its results were unaccountably associated with 
the presence of ERM (84.2%, P,0.005).
The NIR features of macular neovascular lesions and 
AF characteristics of mCNV have been investigated but not 
as thoroughly.5,6,25–27 Using NIR and AF imaging, we were 
unable to define the mCNV features in 29.2% and 41.5% 
of cases, respectively – these are substantial proportions. 
Differences in the patterns may be caused by the typical RPE 
thinning and/or by the RPE cells “coating” the neovascular 
complex. NIR mainly correlates with melanin inside the 
Table 3 Association of mostly statistically relevant angiographic or tomographic characteristics (first column) with corresponding 
subgroups of associated other characteristics (second column)
Characteristics Groups Eyes, n/N (%)* P-value 
Leakage on FA age ,66 years 25/27 (92.59) ,0.05 
age $66 years 25/38 (65.79)
erM anterior to mCnV mCnV area #1 11/40 (27.50) ,0.05
mCnV area .1 14/25 (56.00)
Presence of hF eyes with presence of retinal edema 9/14 (64.29) ,0.05
Eyes with absence of retinal edema 13/51 (25.49)
Presence of MCa eyes with presence of hemorrhage 5/25 (20.00) ,0.01
Eyes with absence of hemorrhage 19/40 (47.50)
Presence of snD eyes with presence of hemorrhage 12/25 (48.50) ,0.005
Eyes with absence of hemorrhage 6/40 (15.00)
Presence of hF eyes with presence of hemorrhage 21/25 (72.00) ,0.05
Eyes with absence of hemorrhage 13/40 (32.50)
shadowing effect eyes with presence of erM 32/38 (84.21) ,0.005
Eyes with absence of ERM 16/27 (59.26)
Presence of hemorrhage eyes with presence of MCa 5/24 (20.83) ,0.05
Eyes with absence of MCA 20/41 (48.78)
FA hyperfluorescence eyes with presence of MCa 12/24 (50.00) ,0.001
Eyes with absence of MCA 3/41 (07.32)
On the border of chorioretinal atrophy Eyes with hyperfluorescence on FA 10/15 (66.67) ,0.0001
 Eyes with leakage on FA 8/50 (16.00)
Presence of snD eyes with presence of hF 11/22 (50.00) ,0.005
Eyes with absence of HF 7/43 (16.28)
Absence of all kinds of retinal edema Eyes with doubtful diagnosis at OCT 13/17 (76.47) ,0.05
eyes with positive diagnosis at OCT 19/48 (39.58)
Presence of hF Eyes with doubtful diagnosis at OCT 2/17 (11.76) ,0.05
eyes with positive diagnosis at OCT 20/48 (41.67)
Presence of hemorrhage Eyes with doubtful diagnosis at OCT
eyes with positive diagnosis at OCT
3/17 (17.65)
31/48 (45.83)
,0.05
Presence of MCa Eyes with doubtful diagnosis at OCT 11/17 (64.71) ,0.01
eyes with positive diagnosis at OCT 13/48 (27.08)
Presence of FA hyperfluorescence Eyes with doubtful diagnosis at OCT 8/17 (47.06) ,0.01
eyes with positive diagnosis at OCT 7/48 (14.58)
Presence of snD Eyes with doubtful diagnosis at OCT 0/17 (00.00) ,0.01
eyes with positive diagnosis at OCT 18/48 (37.50)
On the border of chorioretinal atrophy Eyes with doubtful diagnosis at OCT 9/17 (52.94) ,0.01
eyes with positive diagnosis at OCT 9/48 (18.75)
Leakage on FA Eyes with doubtful diagnosis at OCT 9/17 (52.94) ,0.01
eyes with positive diagnosis at OCT 41/48 (85.42)
Presence of MCa Eyes with doubtful diagnosis at FA 12/16 (75.00) ,0.001
eyes with positive diagnosis at Fa 21/49 (42.86)
Hyperfluorescence Eyes with doubtful diagnosis at FA 11/16 (68.75) ,0.001
eyes with positive diagnosis at Fa 4/49 (08.16)
On the border of chorioretinal atrophy Eyes with doubtful diagnosis at FA 11/16 (68.75) ,0.001
eyes with positive diagnosis at Fa 7/49 (14.29)
Notes: *The relative number/total number in subgroup and percentage of eyes are reported in the third column. Significant Wilcoxon test P-values are listed in the 
last column. 
Abbreviations: FA, fluorescein angiography; ERM, epiretinal membrane; mCNV, myopic choroidal neovascularization; HF, hyper-reflective foci; MCA, macular chorioretinal 
atrophy; snD, serous neuroretinal detachment; OCT, optical coherence tomography.
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RPE27 and, similar to the findings reported in a small sample 
with AMD,26 nearly half of the lesions (49.2%) presented a 
gray or black appearance, surrounded by a whitish or black­
grayish ring in 13 and seven cases, respectively. 
The presence of a reactive, hyperautofluorescent ring 
is partially confirmed by AF imaging, where the main 
finding, unlike to a recent report by Parodi et al,28 was a 
hypo­hyperautofluorescent (“patchy”) rather than a hyperauto­
fluorescent lesion. Autofluorescence is related to the presence 
of lipofuscin in the RPE, and is probably due to the displace­
ment of macular pigments and subsequent increased exposure 
of lipofuscin. In 15/65 (23%) eyes, a hyperautofluorescent 
ring was found around the mCNV. Previously, it has been 
considered secondary to fibrin accumulation,26 but we believe 
that a sort of RPE reactive hyperplasia develops secondary to 
mCNV formation, as confirmed by some studies.29,30
The type of NIR reflectance or AF by the ring or even by 
the lesion itself may be indicative of the different stages of 
RPE hyperplasia or the portion and shape of the neovascular 
membrane complex. 
Angiographic visualization of the mCNV has improved 
greatly since the scanning laser system came into clinical 
practice. Despite Avila’s findings in 1984,31 it is now clear 
that most of the lesions commonly present with at least mild 
leakage. This was seen in 76% of the eyes in our series, 
especially in patients younger than 66 years, whereas in the 
others we detected only some hyperfluorescence and no leak­
age, making diagnosis impossible on the basis of FA alone 
in eleven of these cases. 
In contrast with previous findings7 and with NIR and AF, 
FA and SD­OCT, when used separately, offered overall simi­
lar, discrete good diagnostic sensitivity, although 16 (24.6%) 
and 17 (26.1%) patients, respectively, would not have been 
diagnosed correctly and consequently not properly treated. In 
all these cases, it was direct comparison of the two imaging 
modalities that permitted a correct diagnosis. The presence 
of macular chorioretinal atrophy in 12/16 and 11/17 cases 
was significantly related to a doubtful evaluation either on 
FA or on SD­OCT. Intuitively, the absence of any kind of 
retinal fluid, hemorrhage, and HF also resulted in diagnostic 
difficulties on SD­OCT (P,0.05).
This study has some limitations, such as the small number 
of patients and the lack of masked evaluation of the images 
by several examiners. Interpretation of the NIR and AF 
images was problematic, highly variable, and subjective. 
We must also consider that it may take several weeks for 
some older patients to become aware of their visual loss. 
This partly explains the variability in the size and appear­
ance of lesions at diagnosis. Another limitation is that the 
tomographic evaluation may be influenced by the number 
of sections in the macular volume module. However, this is 
only the first paper to describe multimodal imaging features 
in mCNV.
Conclusion
This study reported a description and correlation of the 
mCNV characteristics on FA, SD­OCT, NIR, and AF. The 
angiographic and tomographic diagnostic sensitivity appear 
to be similar, but the combination of both modalities is rec­
ommendable to achieve the diagnosis in all the cases.
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